Skip to main content
Clinical Trials/NCT02470728
NCT02470728
Terminated
Not Applicable

Pain Management Options for Opioid Tolerant Patients: a Randomized Controlled Trial

Duke University2 sites in 1 country60 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Duke University
Enrollment
60
Locations
2
Primary Endpoint
Returns to Acute Care
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Pain is a symptom that drives hospital admissions, and pain management is required by most patients during their hospital stay. Further, the use of medications such as opioids can lead to upward-spiraling doses, especially among chronic pain patients whose resource utilization rates are high. Many initiatives aim to reduce the costs of these "high-resource utilizing" patients. One exciting aspect of improving the management of pain is that this may help prevent patients from ever becoming high-cost in the first place. The purpose of this study is to examine the impacts of an early and sustained intervention pathway, in comparison to the current standard of care, for the treatment of pain in opioid tolerant patients. It is hypothesized that patients randomized to the intervention pathway, in comparison to the control, will lead to decreased costs of care, a reduction in opioid usage within 3 and 6 months, and decrease in hospital readmission rates.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
July 31, 2019
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients (18 years and older)
  • Known opioid tolerant (as determined per FDA criteria)
  • Agree to sign the informed consent and HIPAA forms

Exclusion Criteria

  • Patients under the age of 18 years
  • No known opioid tolerance
  • Do not agree to sign the informed consent and HIPAA forms

Outcomes

Primary Outcomes

Returns to Acute Care

Time Frame: Discharge through 90 days post-discharge

Hospital Readmissions and Emergency Department Utilizations

Secondary Outcomes

  • Hospital Length of Stay(Measured upon day of discharge from index hospitalization; up to 18 months from the date of randomization)
  • Latency to Hospital Readmission(Discharge through 12 months post-discharge)
  • Returns to Acute Care(Discharge through 12 months post-discharge)
  • Use of Rescue Drugs(Admission through 12 months post-discharge)
  • Opioid Analgesic Use(Admission through 12 months post-discharge)
  • Opioid Tolerance Status(Admission through 12 months post-discharge)
  • Pain at Discharge(Measured upon day of discharge from index hospitalization; up to 18 months from the date of randomization)
  • Healthcare Expenditures(Admission through 12 months post-discharge)

Study Sites (2)

Loading locations...

Similar Trials